Biovest International Inc (BVTI) Financial Statements (2024 and earlier)
Company Profile
Business Address |
324 S HYDE PARK AVE TAMPA, FL 33606 |
State of Incorp. | DE |
Fiscal Year End | September 30 |
Industry (SIC) | 2834 - Pharmaceutical Preparations (benchmarking) |
More info | Complete Financial Analysis Financial Benchmarking |
Balance Sheet (Statement of Financial Position) ($ in thousands)Annual | Quarterly
12/31/2013 Q1 | 9/30/2013 Q4 | 6/30/2013 Q3 | 3/31/2013 Q2 | 12/31/2012 Q1 | |||
---|---|---|---|---|---|---|---|
ASSETS | |||||||
Current Assets | |||||||
Cash, cash equivalents, and short-term investments | 734 | 312 | 242 | 353 | |||
Cash and cash equivalents | 734 | 312 | 242 | 353 | |||
Receivables | 530 | 464 | 286 | 200 | |||
Inventory, net of allowances, customer advances and progress billings | 329 | 560 | 358 | 402 | |||
Inventory | 329 | 560 | 358 | 402 | |||
Prepaid expense and other current assets | ✕ | ✕ | ✕ | 198 | 169 | ||
Costs in excess of billings | 240 | 151 | 91 | 30 | |||
Other undisclosed current assets | 208 | 456 | |||||
Total current assets: | 2,041 | 1,943 | 1,175 | 1,154 | |||
Noncurrent Assets | |||||||
Property, plant and equipment | 1,391 | 1,304 | 867 | 900 | |||
Intangible assets, net (including goodwill) | 39,697 | 2,310 | 2,318 | 2,325 | |||
Goodwill | 3,897 | 2,131 | 2,131 | 2,131 | |||
Intangible assets, net (excluding goodwill) | 35,800 | 179 | 187 | 194 | |||
Other noncurrent assets | 516 | 371 | ✕ | ||||
Prepaid expense and other noncurrent assets | ✕ | ✕ | ✕ | 557 | 578 | ||
Other undisclosed noncurrent assets | (21) | ||||||
Total noncurrent assets: | 41,583 | 3,985 | 3,742 | 3,803 | |||
TOTAL ASSETS: | 43,624 | 5,928 | 4,917 | 4,957 | |||
LIABILITIES AND EQUITY | |||||||
Liabilities | |||||||
Current Liabilities | |||||||
Accounts payable and accrued liabilities | 1,100 | 1,631 | 837 | 7,049 | |||
Accounts payable | 754 | 787 | 252 | 912 | |||
Accrued liabilities | 346 | 844 | 585 | 6,137 | |||
Debt | 147 | 29,174 | |||||
Derivative instruments and hedges, liabilities | 155 | 211 | |||||
Billings in excess of cost | 73 | 56 | 14 | ||||
Other undisclosed current liabilities | 4 | 3,035 | 318 | 8,423 | |||
Total current liabilities: | 1,251 | 4,739 | 1,366 | 44,871 | |||
Noncurrent Liabilities | |||||||
Long-term debt and lease obligation | 391 | 2,833 | |||||
Long-term debt, excluding current maturities | 305 | 2,833 | |||||
Capital lease obligations | 86 | ||||||
Liabilities, other than long-term debt | 10 | 26 | 47 | 73 | |||
Due to related parties | |||||||
Other liabilities | 10 | 26 | 47 | 73 | |||
Other undisclosed noncurrent liabilities | 44,350 | 49,196 | 473 | ||||
Total noncurrent liabilities: | 401 | 44,376 | 49,243 | 3,379 | |||
Total liabilities: | 1,652 | 49,115 | 50,609 | 48,250 | |||
Equity | |||||||
Equity, attributable to parent | 41,972 | (43,187) | (45,692) | (43,293) | |||
Common stock | 1,000 | 1,465 | 1,465 | 1,465 | |||
Additional paid in capital | 42,449 | 131,398 | 131,396 | 131,395 | |||
Accumulated deficit | (1,477) | (176,050) | (178,553) | (176,153) | |||
Equity, attributable to noncontrolling interest | |||||||
Total equity: | 41,972 | (43,187) | (45,692) | (43,293) | |||
TOTAL LIABILITIES AND EQUITY: | 43,624 | 5,928 | 4,917 | 4,957 |
Income Statement (P&L) ($ in thousands)Annual | Quarterly
12/31/2013 Q1 | 9/30/2013 Q4 | 6/30/2013 Q3 | 3/31/2013 Q2 | 12/31/2012 Q1 | ||
---|---|---|---|---|---|---|
Revenues | (2,559) | 1,195 | 815 | 549 | ||
Revenue, net | 1,195 | 815 | 549 | |||
Cost of revenue | 947 | (788) | (578) | (581) | ||
Cost of goods and services sold | 947 | (788) | (578) | (1,781) | ||
Gross profit: | (1,612) | 407 | 237 | (32) | ||
Operating expenses | (2,599) | (2,176) | (1,972) | |||
Other undisclosed operating income | 4,773 | 788 | 578 | 581 | ||
Operating income (loss): | 3,161 | (1,404) | (1,361) | (1,423) | ||
Nonoperating income (expense) | 79 | (798) | (1,843) | |||
Investment income, nonoperating | 150 | 56 | 645 | |||
Interest and debt expense | (71) | (855) | (2,487) | |||
Other undisclosed income from continuing operations before equity method investments, income taxes | 2,562 | 71 | 855 | 2,487 | ||
Income (loss) from continuing operations: | 5,723 | (1,325) | (2,159) | (3,266) | ||
Income (loss) before gain (loss) on sale of properties: | 5,723 | (1,325) | (2,159) | (3,266) | ||
Other undisclosed net income | ||||||
Net income (loss): | 5,723 | (1,325) | (2,159) | (3,266) | ||
Net income attributable to noncontrolling interest | ||||||
Other undisclosed net income (loss) attributable to parent | (3,560) | 3,828 | (241) | |||
Net income (loss) available to common stockholders, diluted: | 2,163 | 2,503 | (2,400) | (3,266) |
Comprehensive Income ($ in thousands)Annual | Quarterly
12/31/2013 Q1 | 9/30/2013 Q4 | 6/30/2013 Q3 | 3/31/2013 Q2 | 12/31/2012 Q1 | ||
---|---|---|---|---|---|---|
Net income (loss): | 5,723 | (1,325) | (2,159) | (3,266) | ||
Comprehensive income (loss): | 5,723 | (1,325) | (2,159) | (3,266) | ||
Comprehensive loss, net of tax, attributable to noncontrolling interest | ||||||
Comprehensive income (loss), net of tax, attributable to parent: | 5,723 | (1,325) | (2,159) | (3,266) |
Statements Sources
The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.